PDS Biotechnology Corporation(PDSB)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

PDSB PDS Biotechnology Corporation

盘前交易 08-13 04:51:07 EDT

0.2420

-0.0148

-5.76%

盘前0.2410

-0.0010-0.41%

04:31 EDT

最高0.2720	最低0.2297	成交量711.15万
今开0.2602	昨收0.2568	日振幅16.47%
总市值1,351万	流通市值1,317万	总股本5,582万
成交额178.35万	换手率13.07%	流通股本5,440万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"PDSB","market":"US","secType":"STK","nameCN":"PDS Biotechnology Corporation","latestPrice":0.242,"timestamp":1786564800000,"preClose":0.2568,"halted":0,"volume":7111450,"hourTrading":{"tag":"盘前","latestPrice":0.241,"preClose":0.242,"latestTime":"04:31 EDT","volume":2803,"amount":681.25519106,"timestamp":1786609903348,"change":-0.001,"changeRate":-0.004132,"amplitude":0.004132},"delay":0,"changeRate":-0.05763239875389401,"floatShares":54404300,"shares":55815700,"eps":-0.665407,"marketStatus":"盘前交易","change":-0.0148,"latestTime":"08-13 04:51:07 EDT","open":0.2602,"high":0.272,"low":0.2297,"amount":1783523.3564290002,"amplitude":0.16472,"askPrice":0.26,"askSize":600,"bidPrice":0.2206,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-0.665407,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1786627800000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1443672000000,"exchange":"NASDAQ","adjPreClose":0.242,"preHourTrading":{"tag":"盘前","latestPrice":0.241,"preClose":0.242,"latestTime":"04:31 EDT","volume":2803,"amount":681.25519106,"timestamp":1786609903348,"change":-0.001,"changeRate":-0.004132,"amplitude":0.004132},"postHourTrading":{"tag":"盘后","latestPrice":0.2353,"preClose":0.242,"latestTime":"19:58 EDT","volume":194127,"amount":46639.07815,"timestamp":1786579101017,"change":-0.0067,"changeRate":-0.027686,"amplitude":0.040083},"volumeRatio":1.2154654540202001,"impliedVol":1.0437,"impliedVolPercentile":0.84},"requestUrl":"/m/hq/s/PDSB","defaultTab":"news","newsList":[{"id":"1133631174","title":"PDS生物技术公司宣布战略重组：聚焦PDS0301进军转移性结直肠癌，并为PDS0101制定合作策略","url":"https://stock-news.laohu8.com/highlight/detail?id=1133631174","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1133631174?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:26","pubTimestamp":1786451201,"startTime":"0","endTime":"0","summary":"PDS生物技术公司（PDS Biotechnology Corporation）近日正式对外宣布一项重大战略调整。此次重组表明，公司将把研发重心全力倾斜至其核心候选药物PDS0301之上，目标直指转移性结直肠癌（mCRC）这一严峻的适应症领域。与此同时，针对另一款关键在研产品PDS0101，管理层也已明确规划出一条全新的合作路径，冀望通过外部联盟来加速其临床开发与商业化进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDSB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116772975","title":"PDS Biotechnology宣布终止对PDS0101三期Versatile-003试验的内部投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1116772975","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116772975?lang=zh_cn&edition=full","pubTime":"2026-08-11 20:26","pubTimestamp":1786451169,"startTime":"0","endTime":"0","summary":"PDS Biotechnology Corporation（代码：PDSB）披露，已决定停止对PDS0101三期Versatile-003临床试验的内部资金投入。这一战略调整意味着，这家生物科技公司不再继续为该项关键试验提供内部资本支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDSB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116114948","title":"PDS Biotechnology Corporation公布NCI主导的转移性结直肠癌二期临床试验第一阶段积极中期数据","url":"https://stock-news.laohu8.com/highlight/detail?id=1116114948","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1116114948?lang=zh_cn&edition=full","pubTime":"2026-04-15 20:46","pubTimestamp":1776257183,"startTime":"0","endTime":"0","summary":"PDS Biotechnology Corporation宣布，其PDS01ADC在由国家癌症研究所（NCI）主导的转移性结直肠癌（MCRC）二期临床试验第一阶段的中期研究数据已正式发表。此次公布的数据显示积极的临床效果，为后续治疗方案的推进提供了重要依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDSB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169029304","title":"PDS Biotechnology Corporation宣布调整三期Versatile-003试验方案 将无进展生存期纳入中期分析主要终点以支持加速审批","url":"https://stock-news.laohu8.com/highlight/detail?id=1169029304","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1169029304?lang=zh_cn&edition=full","pubTime":"2026-02-20 21:31","pubTimestamp":1771594294,"startTime":"0","endTime":"0","summary":"PDS Biotechnology Corporation（简称PDS Biotech）近日公布，其已对三期临床试验Versatile-003的研究方案作出重要修订。新版方案将无进展生存期（PFS）设定为中期分析的主要终点指标，这一调整旨在为后续可能的加速审批提供关键数据支撑。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PDSB","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.pdsbiotech.com","stockEarnings":[{"period":"1week","weight":-0.667},{"period":"1month","weight":-0.6753},{"period":"3month","weight":-0.8308},{"period":"6month","weight":-0.6547},{"period":"1year","weight":-0.8033},{"period":"ytd","weight":-0.6856}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":0.0311},{"period":"3month","weight":0.0325},{"period":"6month","weight":0.1331},{"period":"1year","weight":0.202},{"period":"ytd","weight":0.1328}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"PDS Biotechnology Corporation于2009年1月22日根据特拉华州法律成立。该公司是一家临床阶段的生物技术公司，专注于发现，开发和寻求商业化的新颖的以医院为基础的治疗方案，能够改变治疗模式和危及生命的管理。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.025289},{"month":2,"riseRate":0.454545,"avgChangeRate":-0.061437},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.164348},{"month":4,"riseRate":0.454545,"avgChangeRate":0.079515},{"month":5,"riseRate":0.545455,"avgChangeRate":0.158069},{"month":6,"riseRate":0.454545,"avgChangeRate":-0.000335},{"month":7,"riseRate":0.545455,"avgChangeRate":0.070482},{"month":8,"riseRate":0.272727,"avgChangeRate":-0.069218},{"month":9,"riseRate":0.3,"avgChangeRate":-0.078335},{"month":10,"riseRate":0.3,"avgChangeRate":-0.019658},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.002317},{"month":12,"riseRate":0.272727,"avgChangeRate":-0.051726}],"exchange":"NASDAQ","name":"PDS Biotechnology Corporation","nameEN":"PDS Biotechnology Corporation"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"PDS Biotechnology Corporation(PDSB)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供PDS Biotechnology Corporation(PDSB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"PDS Biotechnology Corporation,PDSB,PDS Biotechnology Corporation股票,PDS Biotechnology Corporation股票老虎,PDS Biotechnology Corporation股票老虎国际,PDS Biotechnology Corporation行情,PDS Biotechnology Corporation股票行情,PDS Biotechnology Corporation股价,PDS Biotechnology Corporation股市,PDS Biotechnology Corporation股票价格,PDS Biotechnology Corporation股票交易,PDS Biotechnology Corporation股票购买,PDS Biotechnology Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"PDS Biotechnology Corporation(PDSB)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供PDS Biotechnology Corporation(PDSB)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}